4//SEC Filing
Nanavaty Maulik 4
Accession 0000950170-23-064982
CIK 0001856725other
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 8:00 AM ET
Size
5.5 KB
Accession
0000950170-23-064982
Insider Transaction Report
Form 4
Nanavaty Maulik
Director
Transactions
- Purchase
Class A Common Stock
2023-11-16$1.98/sh+500$990→ 500 total
Holdings
- 11,017(indirect: By Spouse)
Class A Common Stock
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.97 to $2.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Documents
Issuer
Rani Therapeutics Holdings, Inc.
CIK 0001856725
Entity typeother
Related Parties
1- filerCIK 0001529708
Filing Metadata
- Form type
- 4
- Filed
- Nov 19, 7:00 PM ET
- Accepted
- Nov 20, 8:00 AM ET
- Size
- 5.5 KB